Delivery Order SPE2DB24D2205-SPE2DB25FEFTY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,325.30 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed price contract. This competitively awarded, non-set-aside order was issued on September 23, 2025, with an ultimate completion date of September 24, 2025. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract valued at $4,976.53. The award, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a non-set-aside competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,582.52 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This competitive award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,313.76 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was awarded competitively and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract is valued at $1,807.80 and utilizes firm fixed price terms. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and primary distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,489.84 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order was executed on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a contract ceiling value of $31,642.05. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $3,462.82. This is a firm fixed price delivery order with an ultimate completion date of June 9, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $56,815.09 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) under a firm fixed price contract. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFTYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $39,671.30 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded procurement under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's primary IDC with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs worldwide. AmerisourceBergen serves as a critical vendor for the Defense Health Agency and other federal healthcare systems, and the Jardiance procurement supports diabetes medication requirements within the military medical supply chain. The DLA Troop Support is planning successor generation contracts that may involve multiple regional awards, indicating the agency's continued reliance on qualified pharmaceutical distributors to fulfill federal medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.7k | 8/4/25 |